NO990859D0 - 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater - Google Patents

1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater

Info

Publication number: NO990859D0
Authority: NO; Norway
Prior art keywords: benzofuro; tetrahydro; pyridine
Prior art date: 1997-04-08

Application number

NO990859A

Other languages

English (en)

Other versions

NO990859L (no

NO322826B1 (no

Inventor

Ludo Edmond Josephine Kennis

Christopher John Love

Fran Ois Paul Bischoff

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-08

Filing date

1999-02-23

Publication date

1999-02-23

1999-02-23 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1999-02-23 Publication of NO990859D0 publication Critical patent/NO990859D0/no

1999-09-30 Publication of NO990859L publication Critical patent/NO990859L/no

2006-12-11 Publication of NO322826B1 publication Critical patent/NO322826B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO19990859A 1997-04-08 1999-02-23 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyrinderivater, deres fremstilling, sammensetningen omfattende denne og deres anvendelse. NO322826B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP97201045		1997-04-08
PCT/EP1998/002136 WO1998045297A1 (en)	1997-04-08	1998-04-02	1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES__

Publications (3)

Publication Number	Publication Date
NO990859D0 true NO990859D0 (no)	1999-02-23
NO990859L NO990859L (no)	1999-09-30
NO322826B1 NO322826B1 (no)	2006-12-11

Family

ID=8228191

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19990859A NO322826B1 (no)	1997-04-08	1999-02-23	1,2,3,4-tetrahydro-benzofuro[3,2-c]pyrinderivater, deres fremstilling, sammensetningen omfattende denne og deres anvendelse.

Country Status (31)

Country	Link
US (1)	US6156757A (no)
EP (1)	EP1019408B1 (no)
JP (1)	JP3287577B2 (no)
KR (1)	KR100315975B1 (no)
CN (1)	CN1097053C (no)
AP (1)	AP1138A (no)
AR (1)	AR012576A1 (no)
AT (1)	ATE270294T1 (no)
AU (1)	AU727599B2 (no)
BG (1)	BG63848B1 (no)
BR (1)	BR9806263A (no)
CA (1)	CA2264598C (no)
CZ (1)	CZ290008B6 (no)
DE (1)	DE69824872T2 (no)
EE (1)	EE03691B1 (no)
ES (1)	ES2224391T3 (no)
GE (1)	GEP20022823B (no)
HU (1)	HUP0003624A3 (no)
ID (1)	ID22131A (no)
IL (1)	IL128701A0 (no)
MY (1)	MY120033A (no)
NO (1)	NO322826B1 (no)
NZ (1)	NZ334501A (no)
PL (1)	PL189549B1 (no)
RU (1)	RU2198175C2 (no)
SK (1)	SK283621B6 (no)
TR (1)	TR199900644T2 (no)
TW (1)	TW589315B (no)
UA (1)	UA52681C2 (no)
WO (1)	WO1998045297A1 (no)
ZA (1)	ZA982969B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UA52681C2 (uk) *	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
NZ510116A (en) *	1998-10-06	2002-10-25	Janssen Pharmaceutica Nv	Tricyclic delta-3-piperidines as pharmaceuticals
UA70334C2 (en)	1998-10-06	2004-10-15	Janssen Pharmaceutica N V Jans	BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
BR9916427A (pt) *	1998-12-21	2001-09-04	Janssen Pharmaceutica Nv	Benzisoxazóis e fenonas como alfa2-antagonistas
MXPA04000036A (es) *	2001-07-05	2004-05-21	Upjohn Co	Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
WO2003082825A1 (en) *	2002-04-03	2003-10-09	Orion Corporation	Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
CA2500952C (en) *	2002-10-04	2011-04-26	Prana Biotechnology Limited	Neurologically-active compounds
AU2005233456A1 (en) *	2004-04-12	2005-10-27	Taisho Pharmaceutical Co., Ltd.	Cyclic amine compound
US8470859B2 (en) *	2006-10-23	2013-06-25	Takeda Pharmaceutical Company Limited	Iminopyridine derivative and use thereof
UY31781A (es) *	2008-04-23	2009-12-14	Takeda Pharmaceutical	Derivados de iminopiridina y su uso
US8481569B2 (en)	2008-04-23	2013-07-09	Takeda Pharmaceutical Company Limited	Iminopyridine derivatives and use thereof
US8575186B2 (en) *	2009-10-05	2013-11-05	Albany Molecular Research, Inc.	Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
CA2823955A1 (en) *	2011-01-19	2012-07-26	Albany Molecular Research, Inc.	Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
GB201704325D0 (en) *	2017-03-17	2017-05-03	Argonaut Therapeutics Ltd	Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2570701B1 (fr) *	1984-09-27	1987-05-22	Synthelabo	Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) *	1985-09-03	1987-08-11	Merck & Co., Inc.	Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) *	1988-04-27	1991-03-20	Glaxo Group Limited	Lactam derivatives
UA52681C2 (uk) *	1997-04-08	2003-01-15	Янссен Фармацевтика Н.В.	Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

1998
- 1998-02-04 UA UA99031180A patent/UA52681C2/uk unknown
- 1998-04-02 JP JP54240698A patent/JP3287577B2/ja not_active Expired - Fee Related
- 1998-04-02 AP APAP/P/1999/001650A patent/AP1138A/en active
- 1998-04-02 EE EEP199900114A patent/EE03691B1/xx not_active IP Right Cessation
- 1998-04-02 NZ NZ334501A patent/NZ334501A/en unknown
- 1998-04-02 DE DE69824872T patent/DE69824872T2/de not_active Expired - Lifetime
- 1998-04-02 PL PL98332382A patent/PL189549B1/pl unknown
- 1998-04-02 IL IL12870198A patent/IL128701A0/xx not_active IP Right Cessation
- 1998-04-02 BR BR9806263-8A patent/BR9806263A/pt not_active Application Discontinuation
- 1998-04-02 RU RU99107290/04A patent/RU2198175C2/ru active
- 1998-04-02 US US09/402,593 patent/US6156757A/en not_active Expired - Lifetime
- 1998-04-02 CZ CZ1999682A patent/CZ290008B6/cs not_active IP Right Cessation
- 1998-04-02 ID IDW990147D patent/ID22131A/id unknown
- 1998-04-02 AT AT98921458T patent/ATE270294T1/de not_active IP Right Cessation
- 1998-04-02 EP EP98921458A patent/EP1019408B1/en not_active Expired - Lifetime
- 1998-04-02 SK SK287-99A patent/SK283621B6/sk not_active IP Right Cessation
- 1998-04-02 GE GEAP19985020A patent/GEP20022823B/en unknown
- 1998-04-02 KR KR1019997002086A patent/KR100315975B1/ko not_active IP Right Cessation
- 1998-04-02 TR TR1999/00644T patent/TR199900644T2/xx unknown
- 1998-04-02 ES ES98921458T patent/ES2224391T3/es not_active Expired - Lifetime
- 1998-04-02 WO PCT/EP1998/002136 patent/WO1998045297A1/en active IP Right Grant
- 1998-04-02 CN CN98801286A patent/CN1097053C/zh not_active Expired - Lifetime
- 1998-04-02 CA CA002264598A patent/CA2264598C/en not_active Expired - Lifetime
- 1998-04-02 AU AU74307/98A patent/AU727599B2/en not_active Expired
- 1998-04-02 HU HU0003624A patent/HUP0003624A3/hu unknown
- 1998-04-03 MY MYPI98001502A patent/MY120033A/en unknown
- 1998-04-07 TW TW087105162A patent/TW589315B/zh not_active IP Right Cessation
- 1998-04-07 ZA ZA9802969A patent/ZA982969B/xx unknown
- 1998-04-07 AR ARP980101598A patent/AR012576A1/es active IP Right Grant
1999
- 1999-02-23 NO NO19990859A patent/NO322826B1/no not_active IP Right Cessation
- 1999-02-25 BG BG103213A patent/BG63848B1/bg unknown

Also Published As

Publication number	Publication date
BR9806263A (pt)	2000-04-04
ZA982969B (en)	1999-10-07
RU2198175C2 (ru)	2003-02-10
EP1019408B1 (en)	2004-06-30
CN1097053C (zh)	2002-12-25
EE9900114A (et)	1999-12-15
TW589315B (en)	2004-06-01
EE03691B1 (et)	2002-04-15
BG63848B1 (bg)	2003-03-31
UA52681C2 (uk)	2003-01-15
KR100315975B1 (ko)	2001-12-22
AU727599B2 (en)	2000-12-14
SK28799A3 (en)	2001-03-12
DE69824872T2 (de)	2005-09-01
BG103213A (en)	2000-05-31
MY120033A (en)	2005-08-30
CN1237179A (zh)	1999-12-01
WO1998045297A1 (en)	1998-10-15
AP9901650A0 (en)	1999-09-30
EP1019408A1 (en)	2000-07-19
CA2264598C (en)	2006-10-24
JP3287577B2 (ja)	2002-06-04
CZ68299A3 (cs)	2000-08-16
JP2000505115A (ja)	2000-04-25
HUP0003624A2 (hu)	2001-04-28
DE69824872D1 (de)	2004-08-05
KR20000036076A (ko)	2000-06-26
PL332382A1 (en)	1999-09-13
PL189549B1 (pl)	2005-08-31
AP1138A (en)	2003-01-17
CA2264598A1 (en)	1998-10-15
NO990859L (no)	1999-09-30
ES2224391T3 (es)	2005-03-01
GEP20022823B (en)	2002-10-25
CZ290008B6 (cs)	2002-05-15
NZ334501A (en)	2000-06-23
US6156757A (en)	2000-12-05
NO322826B1 (no)	2006-12-11
AR012576A1 (es)	2000-11-08
HUP0003624A3 (en)	2002-09-30
TR199900644T2 (xx)	2000-09-21
IL128701A0 (en)	2000-01-31
AU7430798A (en)	1998-10-30
SK283621B6 (sk)	2003-10-07
ID22131A (id)	1999-09-09
ATE270294T1 (de)	2004-07-15

Publication	Publication Date	Title
NO2006016I1 (no)	2006-11-27	7,8,9,10-tetrahydro-6H-6,10-metanoazepinoÄ4,5-gÜkinoksalintartrat
PT993456E (pt)	2005-01-31	4,5-diaril-imidazoles 2-substituidos
DE69839398D1 (de)	2008-06-05	Pyridinderivate
DE69736711D1 (de)	2006-11-02	Substituierte 6,5-heterobicyclische-derivate
DK0925298T3 (da)	2004-08-09	Substituerede 6,6-heterobicykliske derivater
ID17659A (id)	1998-01-15	Piridin campuran-bisiklik
ATE435861T1 (de)	2009-07-15	12,13-cyclopropan-epothilonderivate
DK1000048T3 (da)	2003-03-03	Substituerede 1,2,3,4-tetrahydronapthalenderivater
NL300150I1 (nl)	2004-08-02	4"-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten.
ID19773A (id)	1998-07-30	Turunan-turunan 1,3,8-triaza-spiro (4,5) dekan-4-ona tersubtitusi-8
DE69718771D1 (de)	2003-03-06	Substituierte 1,2,3,4-tetrahydronaphthalinderivate
DE69821009D1 (de)	2004-02-12	6,9-verbrückte erythromycin-derivate
ATE239750T1 (de)	2003-05-15	6,11-verbrückte erythromycinderivate
ATE212635T1 (de)	2002-02-15	1,3,8-triazaspiro(4,5)decan-4-on-derivate
NO990859D0 (no)	1999-02-23	1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridinderivater
DE69502542D1 (de)	1998-06-25	2-Phenyl-7-chlor-perhydroimidazo(1,5-a)pyridine
EE200000447A (et)	2001-12-17	1,3,4-oksadiasolooni derivaadid
DK1068200T3 (da)	2005-06-20	2,4,4-trisubstituerede-1,3-dioxolanfungicider
ID24047A (id)	2000-07-06	Turunan 5-tersubstitusi-3-oksaziazolil 1,6-naftiridin-2 1h-on
ATE240941T1 (de)	2003-06-15	1,25-dihydroxy-16,22,23-trisdehydro- cholecalciferol-derivate
NO962931D0 (no)	1996-07-12	N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat
KR970049130U (ko)	1997-08-12	그네판

Legal Events

Date	Code	Title	Description
2010-11-29	MM1K	Lapsed by not paying the annual fees